Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Section of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas USA.
Am J Gastroenterol. 2024 Feb 1;119(2):287-296. doi: 10.14309/ajg.0000000000002455. Epub 2023 Sep 27.
Hospital readmissions are common in patients with cirrhosis, but there are few studies describing readmission preventability. We aimed to describe the incidence, causes, and risk factors for preventable readmission in this population.
We performed a prospective cohort study of patients with cirrhosis hospitalized at a single center between June 2014 and March 2020 and followed up for 30 days postdischarge. Demographic, clinical, and socioeconomic data, functional status, and quality of life were collected. Readmission preventability was independently and systematically adjudicated by 3 reviewers. Multinomial logistic regression was used to compare those with (i) preventable readmission, (ii) nonpreventable readmission/death, and (iii) no readmission.
Of 654 patients, 246 (38%) were readmitted, and 29 (12%) were preventable readmissions. Reviewers agreed on preventability for 70% of readmissions. Twenty-two (including 2 with preventable readmission) died. The most common reasons for readmission were hepatic encephalopathy (22%), gastrointestinal bleeding (13%), acute kidney injury (13%), and ascites (6%), and these reasons were similar between preventable and nonpreventable readmissions. Preventable readmission was often related to paracentesis timeliness, diuretic adjustment monitoring, and hepatic encephalopathy treatment. Compared with nonreadmitted patients, preventable readmission was independently associated with racial and ethnic minoritized individuals (odds ratio [OR] 5.80; 95% CI, 1.96-17.13), nonmarried marital status (OR 2.88; 95% CI, 1.18-7.05), and admission in the prior 30 days (OR 3.45; 95% CI, 1.48-8.04).
For patients with cirrhosis, readmission is common, but most are not preventable. Preventable readmissions are often related to ascites and hepatic encephalopathy and are associated with racial and ethnic minorities, nonmarried status, and prior admissions.
肝硬化患者的住院再入院较为常见,但很少有研究描述其可预防性。本研究旨在描述该人群中再入院的发生率、原因和可预防性因素。
我们对 2014 年 6 月至 2020 年 3 月期间在单中心住院的肝硬化患者进行了前瞻性队列研究,并在出院后 30 天进行了随访。收集了人口统计学、临床和社会经济数据、功能状态和生活质量。再入院的可预防性由 3 名评审员进行独立和系统的裁定。多分类逻辑回归用于比较(i)可预防性再入院、(ii)非可预防性再入院/死亡和(iii)无再入院患者。
654 例患者中,246 例(38%)再入院,29 例(12%)为可预防性再入院。评审员对 70%的再入院达成了可预防性的一致意见。22 例患者死亡(包括 2 例可预防性再入院患者)。再入院的最常见原因是肝性脑病(22%)、胃肠道出血(13%)、急性肾损伤(13%)和腹水(6%),这些原因在可预防性和非可预防性再入院中相似。可预防性再入院常与放腹水的及时性、利尿剂调整监测和肝性脑病治疗有关。与未再入院患者相比,可预防性再入院与种族和民族少数人群(比值比[OR] 5.80;95%置信区间[CI],1.96-17.13)、非已婚婚姻状况(OR 2.88;95%CI,1.18-7.05)和入院前 30 天(OR 3.45;95%CI,1.48-8.04)相关。
对于肝硬化患者,再入院很常见,但大多数是不可预防的。可预防性再入院通常与腹水和肝性脑病有关,与少数民族、非已婚状态和既往入院有关。